Title : MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.

Pub. Date : 2015 Oct 6

PMID : 26311740






9 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. Sorafenib microRNA 21 Homo sapiens
2 Differential screening of miRNAs showed higher levels of miR-21 in sorafenib-resistant HCC cells. Sorafenib microRNA 21 Homo sapiens
3 Exposure of HCC cells to sorafenib led to an increase in miR-21 expression, a decrease in PTEN expression and sequential Akt activation. Sorafenib microRNA 21 Homo sapiens
4 Transfection of miR-21 mimics in HCC cells restored sorafenib resistance by inhibiting autophagy. Sorafenib microRNA 21 Homo sapiens
5 Anti-miR-21 oligonucleotides re-sensitized sorafenib-resistant cells by promoting autophagy. Sorafenib microRNA 21 Homo sapiens
6 Inhibition of miR-21 enhances the efficacy of sorafenib in treating sorafenib-resistant HCC tumors in vivo. Sorafenib microRNA 21 Homo sapiens
7 Inhibition of miR-21 enhances the efficacy of sorafenib in treating sorafenib-resistant HCC tumors in vivo. Sorafenib microRNA 21 Homo sapiens
8 We conclude that miR-21 participates in the acquired resistance of sorafenib by suppresing autophagy through the Akt/PTEN pathway. Sorafenib microRNA 21 Homo sapiens
9 MiR-21 could serve as a therapeutic target for overcoming sorafenib resistance in the treatment of HCC. Sorafenib microRNA 21 Homo sapiens